Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Treatment
89 results:

  • 1. SiRNF8 Delivered by DNA Framework Nucleic Acid Effectively Sensitizes Chemotherapy in Colon cancer.
    Guo Z; Song H; Tian Y; Xu J; Zhang G; Guo Y; Shen R; Wang D
    Int J Nanomedicine; 2024; 19():171-188. PubMed ID: 38204601
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Up-regulation of abcg2 by MYBL2 deletion drives Chlorin e6-mediated photodynamic therapy resistance in colorectal cancer.
    Hui YJ; Chen H; Peng XC; Li LG; Di MJ; Liu H; Hu XH; Yang Y; Zhao KL; Li TF; Yu TT; Wang WX
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103558. PubMed ID: 37030434
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Enzyme-catalyzed synthesis of selenium-doped manganese phosphate for synergistic therapy of drug-resistant colorectal cancer.
    Pei M; Liu K; Qu X; Wang K; Chen Q; Zhang Y; Wang X; Wang Z; Li X; Chen F; Qin H; Zhang Y
    J Nanobiotechnology; 2023 Mar; 21(1):72. PubMed ID: 36859296
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Novel 5-Fluorouracil Loaded Ruthenium-based Nanocarriers Enhanced Anticancer and Apoptotic Efficiency while Reducing Multidrug Resistance in colorectal cancer Cells.
    Danişman-Kalindemirtaş F; Özerkan D; Kariper İA; Bulut H
    J Fluoresc; 2023 May; 33(3):1227-1236. PubMed ID: 36811696
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Enhancement of the antitumor effect of 5-fluorouracil with modulation in drug transporters expression using PI3K inhibitors in colorectal cancer cells.
    El-Daly SM; Abo-Elfadl MT; Hussein J; Abo-Zeid MAM
    Life Sci; 2023 Feb; 315():121320. PubMed ID: 36574946
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis.
    Ghosh S; Singh R; Vanwinkle ZM; Guo H; Vemula PK; Goel A; Haribabu B; Jala VR
    Theranostics; 2022; 12(12):5574-5595. PubMed ID: 35910798
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Rationally Screened and Designed abcg2-Binding Aptamers for Targeting cancer Stem Cells and Reversing Multidrug Resistance.
    Ma Y; Guo Z; Fan C; Chen J; Xu S; Liu Z
    Anal Chem; 2022 May; 94(20):7375-7382. PubMed ID: 35544739
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Methionine restriction enhances the chemotherapeutic sensitivity of colorectal cancer stem cells by miR-320d/c-Myc axis.
    Liu C; Wang JL; Wu DZ; Yuan YW; Xin L
    Mol Cell Biochem; 2022 Jul; 477(7):2001-2013. PubMed ID: 35394639
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Inhibiting the Activity of abcg2 by KU55933 in colorectal cancer.
    Liu K; Chen Y; Shi XB; Xing ZH; He ZJ; Wang ST; Li YC; Liu WJ; Zhang PW; Yu ZZ; Mo XM; Shi XY; Chen ZS; Shi Z
    Recent Pat Anticancer Drug Discov; 2022; 17(4):387-395. PubMed ID: 35023460
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Reversal of abcg2/bcrp-Mediated Multidrug Resistance by 5,3',5'-Trihydroxy-3,6,7,4'-Tetramethoxyflavone Isolated from the Australian Desert Plant
    Petersen MJ; Lund XL; Semple SJ; Buirchell B; Franzyk H; Gajhede M; Kongstad KT; Stenvang J; Staerk D
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680166
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable colorectal cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition.
    Siri M; Behrouj H; Dastghaib S; Zamani M; Likus W; Rezaie S; Hudecki J; Khazayel S; Łos MJ; Mokarram P; Ghavami S
    Arch Immunol Ther Exp (Warsz); 2021 Sep; 69(1):26. PubMed ID: 34536148
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Thymoquinone chemosensitizes human colorectal cancer cells to imatinib via uptake/efflux genes modulation.
    Thabet NA; El-Khouly D; Sayed-Ahmed MM; Omran MM
    Clin Exp Pharmacol Physiol; 2021 Jun; 48(6):911-920. PubMed ID: 33783002
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and abcg2 polymorphisms in patients with metastatic colorectal cancers.
    Kobayashi K; Sugiyama E; Shinozaki E; Wakatsuki T; Tajima M; Kidokoro H; Aoyama T; Nakano Y; Kawakami K; Hashimoto K; Suenaga M; Ichimura T; Ogura M; Chin K; Nakayama I; Ooki A; Takahari D; Suzuki W; Yokokawa T; Minowa Y; Hiraoka T; Suzuki K; Sato H; Hama T; Yamaguchi K
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):767-777. PubMed ID: 33635392
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
    Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer.
    Zhang Q; Zhao H; Wu D; Cao D; Ma W
    BMC Microbiol; 2020 Oct; 20(1):308. PubMed ID: 33050883
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway.
    Yu T; An Q; Cao XL; Yang H; Cui J; Li ZJ; Xiao G
    Life Sci; 2020 Nov; 260():118294. PubMed ID: 32818544
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical Implications of cancer Stem Cell Markers and ABC Transporters as a Predictor of Prognosis in colorectal cancer Patients.
    Kim BH; Oh HK; Kim DW; Kang SB; Choi Y; Shin E
    Anticancer Res; 2020 Aug; 40(8):4481-4489. PubMed ID: 32727778
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. abcg2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic colorectal cancer.
    Palshof JA; Cederbye CN; Høgdall EVS; Poulsen TS; Linnemann D; Nygaard SB; Stenvang J; Christensen IJ; Jensen BV; Pfeiffer P; Brünner N; Yilmaz M; Viuff BM; Nielsen DL
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708825
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. β-Sitosterol Reverses Multidrug Resistance via bcrp Suppression by Inhibiting the p53-MDM2 Interaction in colorectal cancer.
    Wang Z; Zhan Y; Xu J; Wang Y; Sun M; Chen J; Liang T; Wu L; Xu K
    J Agric Food Chem; 2020 Mar; 68(12):3850-3858. PubMed ID: 32167760
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. IRE1α-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cells.
    Gao Q; Li XX; Xu YM; Zhang JZ; Rong SD; Qin YQ; Fang J
    Cancer Lett; 2020 Apr; 476():67-74. PubMed ID: 32061752
    [TBL] [Abstract] [Full Text] [Related]  


    of 5.